Cleaved endocan acts as a biologic competitor of endocan in the control of ICAM-1-dependent leukocyte diapedesis.


Journal

Journal of leukocyte biology
ISSN: 1938-3673
Titre abrégé: J Leukoc Biol
Pays: England
ID NLM: 8405628

Informations de publication

Date de publication:
05 2020
Historique:
received: 15 11 2019
revised: 10 03 2020
accepted: 11 03 2020
pubmed: 10 4 2020
medline: 5 11 2020
entrez: 10 4 2020
Statut: ppublish

Résumé

Dysregulated leukocyte diapedesis is a major contributor to acute severe inflammatory states like sepsis and acute respiratory distress syndrome, which are common conditions in critically ill subjects. Endocan is a circulating proteoglycan that binds to the leukocyte integrin LFA-1 and blocks its interaction with its endothelial ligand ICAM-1, subsequently leading to the inhibition of leukocyte recruitment. Recent data have highlighted the hypothetic role of p14, endocan's major catabolite found in the bloodstream of septic patients, as a potential antagonist of endocan, thus participating in the regulation of acute inflammation. We hereby characterize the role of p14 as a biologic competitor of endocan, through assessment of its molecular interactions with LFA-1, endocan, and ICAM-1, as well as its effects on human leukocyte trafficking. Using immunodetection assay, we report that p14 can bind to LFA-1, thus inhibiting the interaction between LFA-1 and endocan, which in turn leads to the restoration of the ICAM-1/LFA-1 interaction. In primary human T cells trafficking assays, we underline the absence of effect of p14 on ICAM-1-dependent adhesion and migration, as well as on transendothelial migration. However, in those models, p14 reverses the antimigratory effect of endocan. To conclude, our study supports the hypothesis of an antagonistic role of p14 versus endocan in its effect on the LFA-1/ICAM-1-dependent human leukocyte recruitment.

Identifiants

pubmed: 32272492
doi: 10.1002/JLB.3AB0320-612RR
doi:

Substances chimiques

ESM1 protein, human 0
ICAM1 protein, human 0
Lymphocyte Function-Associated Antigen-1 0
Neoplasm Proteins 0
Proteoglycans 0
Intercellular Adhesion Molecule-1 126547-89-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

833-841

Informations de copyright

©2020 Society for Leukocyte Biology.

Références

ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526-2533.
Levitt JE, Matthay MA. Clinical review: Early treatment of acute lung injury - paradigm shift toward prevention and treatment prior to respiratory failure. Crit Care. 2012;16:223.
Béchard D, Scherpereel A, Hammad H, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol Baltim Md 1950. 2001;167:3099-3106.
Gaudet A, Portier L, Prin M, et al. Endocan regulates acute lung inflammation through control of leukocyte diapedesis. J Appl Physiol Bethesda Md 1985. 2019;127:668-678.
Gaudet A, Parmentier E, Dubucquoi S, et al. Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock. J Crit Care. 2018;47:121-126.
Ioakeimidou A, Pagalou E, Kontogiorgi M, et al. Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction. Eur J Clin Microbiol Infect Dis. 2017;36:1749-1756.
Mikkelsen ME, Shah CV, Scherpereel A, et al. Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care. 2012;27:522.e11-17.
Palud A, Parmentier-Decrucq E, Pastre J, et al. Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients. Cytokine. 2015;73:213-218.
Gaudet A, Parmentier E, Dubucquoi S, et al. The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome. Crit Care Lond Engl. 2019;23:86.
De Freitas Caires N, Legendre B, Parmentier E, et al. Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis. J Pharm Biomed Anal. 2013;78-79:45-51.
Yassine H, De Freitas Caires N, Depontieu F, et al. The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction. Oncotarget. 2015;6:2725-2735.
Naeim F, Nagesh Rao P, Song SX, et al. 2 - Principles of Immunophenotyping. In: Naeim F, Nagesh Rao P, Song SX, et al., eds. Atlas of Hematopathology. Academic Press; 2013;25-46.
Ding ZM, Babensee JE, Simon SI, et al. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol Baltim Md 1950. 1999;163:5029-5038.
Green CE, Schaff UY, Sarantos MR, et al. Dynamic shifts in LFA-1 affinity regulate neutrophil rolling, arrest, and transmigration on inflamed endothelium. Blood. 2006;107:2101-2111.
Sarantos MR, Zhang H, Schaff UY, et al. Transmigration of neutrophils across inflamed endothelium is signaled through LFA-1 and Src family kinase. J Immunol Baltim Md 1950. 2008;181:8660-8669.
Smith A, Stanley P, Jones K, et al. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol Rev. 2007;218:135-146.
Smith A, Bracke M, Leitinger B, et al. LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment. J Cell Sci. 2003;116:3123-3133.
Walling BL, Kim M. LFA-1 in T cell migration and differentiation. Front Immunol. 2018;9:952.
Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-689.
Ma Q, Shimaoka M, Lu C, et al. Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1. J Biol Chem. 2002;277:10638-10641.
Zafrani L, Resche-Rigon M, De Freitas Caires N, et al. Endothelial cell-specific molecule-1 in critically Ill patients with hematologic malignancy. Crit Care Med. 2018;46:e250-e257.
Gaudet A, Parmentier E, De Freitas Caires N, et al. Decrease of the plasmatic endocan cleavage ratio is associated with the hyperinflammatory phenotype of acute respiratory distress syndrome. Crit Care. 2019;23:252.

Auteurs

Alexandre Gaudet (A)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, Lille, France.

Lucie Portier (L)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
Biothelis, Lille, France.

Daniel Mathieu (D)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, Lille, France.

Maxence Hureau (M)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
CHU Lille, Pôle de Réanimation, Hôpital Roger Salengro, Lille, France.

Anne Tsicopoulos (A)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
Institut Pasteur de Lille, Lille, France.
CHU Lille, Pôle de Pneumologie, Hôpital Calmette, Lille, France.

Philippe Lassalle (P)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
Institut Pasteur de Lille, Lille, France.

Nathalie De Freitas Caires (N)

Center for Infection and Immunity of Lille, University of Lille, U1019 - UMR 8204, Lille, France.
CNRS, UMR 8204, Lille, France.
INSERM, U1019, Lille, France.
Biothelis, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH